Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 16Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Non-Hodgkin 10Lymphoma 9Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia 8Recurrence 6Hodgkin Disease 6Myeloproliferative Disorders 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Neoplasms 4Neoplasm, Residual 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Lymphoid 4Immunoproliferative Disorders 4Immune System Diseases 4Burkitt Lymphoma 4Precancerous Conditions 3Lymphoproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Lymphatic Diseases 3Leukemia, Myelomonocytic, Chronic 3

Interventions

Cisplatin 11Gemcitabine 10Radiotherapy, Intensity-Modulated 6Capecitabine 6Drug Therapy 3Docetaxel 3toripalimab 2spartalizumab 2pembrolizumab 2nimotuzumab 2fludarabine 2atezolizumab 2Specimen Handling 2Platinum 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fluorouracil 2Disulfides 2Cyclophosphamide 2Carboplatin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2tislelizumab 1sintilimab 1penpulimab 1olaparib 1fludarabine phosphate 1dehydroftorafur 1camrelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Nasopharyngeal Carcinoma × fludarabine phosphate × Clear all
NCT02287311 2026-03-23

MABEL

Baylor College of Medicine

Phase 1 Active not recruiting
38 enrolled 16 charts
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Smooth Muscle Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡